← Back to Search

Text Message Reminders for Cervical Cancer Screening

N/A
Recruiting
Led By David Adler, MD
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
female
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 150 days
Awards & highlights

Study Summary

This trial will test whether text message reminders can help women keep up with recommended cervical cancer screenings.

Who is the study for?
This trial is for English, Spanish, or ASL-speaking women aged 21-65 who can make their own medical decisions. It's not for those without a cervix due to surgery like hysterectomy, HIV-positive individuals (due to different screening needs), or anyone unable to consent at the time.Check my eligibility
What is being tested?
The study tests if text message prompts can help more women visiting the emergency department get screened for cervical cancer. The goal is to see if mobile technology can improve screening rates among patients.See study design
What are the potential side effects?
Since this intervention involves sending SMS prompts and does not include medication or invasive procedures, there are no direct physical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are a woman.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~150 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 150 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of screening for cervical cancer
Secondary outcome measures
Self-administered vs in-person baseline technique

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Self-Administered TreatmentExperimental Treatment1 Intervention
Treatment group (receives text messages), initial screening measures conducted on their own via an iPad.
Group II: In-person TreatmentExperimental Treatment1 Intervention
Treatment group (receives text messages), initial screening measures conducted in-person in the Emergency Department.
Group III: in-person controlActive Control1 Intervention
Usual care, initial screening measures conducted in-person in the Emergency Department.
Group IV: Self-Administered ControlActive Control1 Intervention
Usual care, initial screening measures conducted on their own via an iPad.

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
836 Previous Clinical Trials
516,708 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,931,693 Total Patients Enrolled
David Adler, MDPrincipal Investigator - University of Rochester
Strong Memorial Hospital
University Of California (Medical School)
Alameda Co Medical Center (Residency)
1 Previous Clinical Trials
303 Total Patients Enrolled

Media Library

SMS-intervention Clinical Trial Eligibility Overview. Trial Name: NCT04374760 — N/A
Cervical Cancer Research Study Groups: In-person Treatment, in-person control, Self-Administered Control, Self-Administered Treatment
Cervical Cancer Clinical Trial 2023: SMS-intervention Highlights & Side Effects. Trial Name: NCT04374760 — N/A
SMS-intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04374760 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor currently have capacity for new participants?

"Affirmative, the information hosted on clinicaltrials.gov reveals that this examination is currently seeking participants. The investigation was initially posted in December of 2020 and most recently updated in May 2022- with a goal of recruiting 1460 individuals from 2 sites."

Answered by AI

Who qualifies to partake in this research initiative?

"For this research undertaking, 1460 participants aged 21 - 65 years old and of the female gender will be accepted. Additionally, these individuals must have decisional capacity to consent to participation in order to qualify for inclusion."

Answered by AI

Does this research trial accommodate geriatric volunteers aged 75 or below?

"The eligibility requirements for this clinical investigation necessitate that candidates are between the ages of 21 and 65."

Answered by AI

How many subjects have participated in this research endeavor?

"Confirmed. Clinicaltrials.gov data shows that this medical trial, initiated on December 3rd 2020, is currently looking for volunteers to join the study. Specifically, 1460 participants are needed from 2 separate sites."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
Nicolas Noyes Community Hospital
What portion of applicants met pre-screening criteria?
Met criteria
~337 spots leftby Apr 2025